Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Nice Insight
154 Articles Available
0
7
Can't find what you're looking for? Try our
advanced search
.
Nice Insight Reports
Biotech Funding Ups and Downs
PAO-04-24-NI-01
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
PAO-03-24-NI-02
Nice Insight API Report
Small Molecule API Discovery and Development Trends
PAO-03-24-NI-01
Cell and Gene Therapy
View from the Top: Cell and Gene Therapy Successes and Promise
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
PAO-04-23-CL-01
API
Small Molecule API Market Trends
PAO-06-022--NI-11
Column: M&A
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
PAO-03-022-NI-08
Column: Regional
Expanding the Cell and Gene Therapy Ecosystem in Philadelphia
PAO-12-21-CL-05
Sterile
Sterile Injectables Device and Packaging Trends
PAO-02-022-NI-01
Synthetic Biology
An Unnatural Phenomenon: How Synthetic Biology May Disrupt Pharma and Beyond
PAO-06-21-NI-02
Curative Therapies
Innovation vs Monetization: The Curative Therapy Conundrum
PAO-06-21-NI-03
Genetic Vaccines
Working to Overcome Analytical Challenges Posed by Genetic Vaccines
PAO-06-21-NI-01
Vaccines
A Look at Genetic Vaccine Development and Manufacturing
PAO-05-21-NI-03
COVID-19 Vaccines
The COVID-19 Vaccine Journey Continues
PAO-05-21-NI-02
Virtual Reality
Perception is Reality: Integrating Virtual and Augmented Reality Across Pharma
PAO-04-21-NI-02
Cell and Gene Therapy
CAR-T Cell and Gene Therapy Market: Challenges and Opportunities
The Road to 2021
Checking in with the Road to 2021 Team
PAO-04-22-R221-24
Feature Story
Wearable Technology: Innovation, Adherence, and Clinical Outcomes
PAP-Q4-20-NI-002
Feature Story
Wearable Technology: Targeting a Range of Uses and Indications
PAP-Q4-20-NI-003
Feature Story
Wearable Technology: Their Future in Clinical Trials and the Real World
PAP-Q4-20-NI-004
CRISPR-Cas9
How Close Is CRISPR to Eradicating Disease and Correcting Genetic Defects?
PAP-Q1-20-NI-003
Cultural Intelligence
Is the Pharma Industry Developing Cultural Intelligence?
PAP-Q1-20-NI-010
Expression Systems
Choosing the Right Expression Platform for Biologics
PAP-Q3-19-NI-005
M&A
FLAMMA Acquires Teva’s Philadelphia cGMP Facility Marking Entry into the US Marketplace with Labs & Pilot Plant
PR-M07-19-NI-013
«
0
7
»
.svg)
